Poor patient survival is associated with higher expression of TNF-α because TNF-α is a proinflammatory cytokine whose expression increases during tumor progression.10 Overexpression of HER-2 in breast cancer can regulate antiapoptotic signals.9 Here, ERBB2 is linked to breast cancer.